poisar

Stocks · News reference

ENDRA Life Sciences Q2 EPS $0.06 Beats $(0.84) Estimate

BenzingaBenzinga Newsdesk

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.84) by 107.14 percent. This is a 103.51 percent increase over losses of $(1.71) per share

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — ENDRA Life Sciences Inc. (NDRA)

    Filed: 2026-08-17 AccNo: 0001213900-26-090747 Size: 272 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits